GRTS logo

Gritstone bio, Inc. Common Stock


GRTS: Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.


Show GRTS Financials

Consumer Interest
SEC Filings

Recent trades of GRTS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by GRTS's directors and management

Government lobbying spending instances

  • $10,000 Apr 20, 2021 Issue: Pharmacy
  • $30,000 Aug 03, 2020 Issue: Pharmacy
U.S. Patents

New patents grants

  • Patent Title: Modified adenoviruses Feb. 28, 2023
  • Patent Title: Alphavirus antigen vectors Nov. 29, 2022
  • Patent Title: Alphavirus neoantigen vectors Nov. 22, 2022
  • Patent Title: Alphavirus neoantigen vectors Aug. 23, 2022
  • Patent Title: Neoantigen identification using hotspots Mar. 01, 2022
  • Patent Title: Neoantigen identification, manufacture, and use Nov. 23, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GRTS in WallStreetBets Daily Discussion


Recent insights relating to GRTS

CNBC Recommendations

Recent picks made for GRTS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRTS

Corporate Flights

Flights by private jets registered to GRTS